Söndag 27 April | 10:29:51 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2025-11-27 09:50 Kvartalsrapport 2025-Q3
2025-08-28 09:50 Kvartalsrapport 2025-Q2
2025-06-25 N/A X-dag ordinarie utdelning PRLD 0.00 SEK
2025-06-24 N/A Årsstämma
2025-05-30 09:50 Kvartalsrapport 2025-Q1
2025-02-28 - Bokslutskommuniké 2024
2024-11-27 - Kvartalsrapport 2024-Q3
2024-08-28 - Kvartalsrapport 2024-Q2
2024-05-27 - Årsstämma
2024-05-17 - Kvartalsrapport 2024-Q1
2024-05-15 - X-dag ordinarie utdelning PRLD 0.00 SEK
2024-02-21 - Bokslutskommuniké 2023
2023-11-27 - Extra Bolagsstämma 2023
2023-11-27 - Kvartalsrapport 2023-Q3
2023-08-29 - Kvartalsrapport 2023-Q2
2023-05-12 - X-dag ordinarie utdelning PRLD 0.00 SEK
2023-05-11 - Årsstämma
2023-05-11 - Kvartalsrapport 2023-Q1
2023-02-21 - Bokslutskommuniké 2022
2022-11-30 - Kvartalsrapport 2022-Q3
2022-08-29 - Kvartalsrapport 2022-Q2
2022-08-04 - Extra Bolagsstämma 2022
2022-05-23 - X-dag ordinarie utdelning PRLD 0.00 SEK
2022-05-20 - Årsstämma
2022-05-20 - Kvartalsrapport 2022-Q1
2022-02-22 - Bokslutskommuniké 2021
2021-11-23 - Kvartalsrapport 2021-Q3
2021-08-31 - Kvartalsrapport 2021-Q2
2021-05-06 - X-dag ordinarie utdelning PRLD 0.00 SEK
2021-05-05 - Årsstämma
2021-05-05 - Kvartalsrapport 2021-Q1
2021-02-24 - Bokslutskommuniké 2020
2020-11-17 - Kvartalsrapport 2020-Q3
2020-08-28 - Kvartalsrapport 2020-Q2
2020-05-21 - X-dag ordinarie utdelning PRLD 0.00 SEK
2020-05-20 - Årsstämma
2020-05-14 - Kvartalsrapport 2020-Q1
2020-02-13 - Bokslutskommuniké 2019
2019-11-20 - Kvartalsrapport 2019-Q3
2019-08-28 - Kvartalsrapport 2019-Q2
2019-05-16 - Årsstämma
2019-05-16 - Kvartalsrapport 2019-Q1
2019-05-10 - X-dag ordinarie utdelning PRLD 0.00 SEK
2018-11-20 - Kvartalsrapport 2018-Q3
2018-08-28 - Kvartalsrapport 2018-Q2
2018-05-17 - X-dag ordinarie utdelning PRLD 0.00 SEK
2018-05-16 - Årsstämma
2018-05-16 - Kvartalsrapport 2018-Q1
2018-02-14 - Bokslutskommuniké 2017
2017-11-23 - Kvartalsrapport 2017-Q3
2017-08-25 - Kvartalsrapport 2017-Q2
2017-05-22 - X-dag ordinarie utdelning PRLD 0.00 SEK
2017-05-19 - Årsstämma
2017-05-19 - Kvartalsrapport 2017-Q1

Beskrivning

LandSverige
ListaNordic SME Sweden
SektorHälsovård
IndustriMedicinteknik
Prolight Diagnostics utvecklar testsystem inom POCT (Point of care testning). Testerna används utanför sjukhuslaboratorium för att möjliggöra snabba bedömningar av patienters hälsa. Bolagets POCT-Plattform är i utveckling med avsikt att mäta flera biomarkörer samtidigt. En viktig del i arbetet är således att korta ner tiden för provresultaten, särskilt viktigt för patienter med hjärtbesvär. Bolaget grundades år 1999 och har sitt huvudkontor i Lund.
2023-02-20 08:00:00

Prolight Diagnostics (“Prolight”) today announces that it has selected Integrated Technologies Limited (“ITL”) to develop the commercial instrument for its point-of-care digital immunoassay system.

This next stage of product development builds on the prototypes developed in-house at Prolight’s subsidiary Psyros Diagnostics (“Psyros”) and will ensure that the commercial instrument is state of the art and in compliance with all regulatory standards required for an IVD.

“We believe the best approach is to partner with experts in their field who can help us deliver on our vision to develop ground-breaking products for our customers. Partnering with ITL gives us an outstanding combination of technical expertise, track-record, flexibility, longer-term manufacturing capability and regulatory compliance,” said Paul Monaghan, head of engineering at Psyros.

“We are excited to join the Psyros adventure as an external partner. The team is highly capable, and it has come up with a most innovative, yet simple and elegant new IVD technology which promises to improve point of care testing worldwide. We will bring our strong capabilities and skills in the field of optics, mechanical engineering, and intimate knowledge of the manufacturing process to the table,” said Tom Ackrill, Business Development Manager at ITL.

About ITL (a G&H Company)
ITL is a specialist design and development company with significant experience in medical devices. In addition to this, ITL has the commercial scale manufacturing capability and is ISO 13485 & ISO 9001 accredited.

For over four decades, ITL has been an industry-leading outsource partner for true end-to-end design, development, and manufacturing of life-saving medical technology, diagnostic devices, and laboratory instruments. In August 2018, ITL was acquired by Gooch & Housego PLC. As part of the wider G&H Group, ITL has wide access to technology, expertise, and resources from the whole group.

About G&H
G&H is a world leader in optical designing, testing and manufacturing. As experts in the technology of light, G&H works with customers to provide optical systems, assemblies, and components for demanding applications.

Headquartered in Ilminster Somerset, UK with operations in the USA and Europe, G&H is recognized for the breadth of their acousto-optic, electro-optic, crystal-optic, fibre optic, and precision optic products. G&H is recognised as the preferred source for OEMs in the life sciences, industrial, and aerospace and defence industries, with a history of quality and excellence that dates back seventy-five years.